Upinder Singh MD
Professor and Division Chief, Infectious Diseases, Stanford University Medical Center
Join to View Full Profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-4379
Fax+1 319-356-4379
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Infectious Disease, 1995 - 1998- University of Virginia Medical CenterResidency, Internal Medicine, 1992 - 1995
Ohio State University College of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 2002 - 2027
IA State Medical License 2025 - 2027
VA State Medical License 1995 - 2002
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- 1 citationsEfficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.Onyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, Upinder Singh, Masaharu Shinkai
The Lancet. Infectious Diseases. 2025-12-01 - Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin, Mady Hornig, Jarrod M Mosier
Nature Communications. 2025-11-17 - Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial.Prasanna Jagannathan, Haley Hedlin, Jane W Liang, Blake Shaw, Evan Maestri
Open Forum Infectious Diseases. 2025-10-01
Journal Articles
- Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist WorkforceWendy Armstrong, Ebbing Lautenbach, Kyle J Popovich, C Buddy Creech, Roger Bedimo, Upinder Singh, Jatin M Vyas, The Journal of Infectious Diseases
Press Mentions
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers ReportJanuary 6th, 2025- Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 InfectionJune 7th, 2024
- Long Covid Patients Abandon Stanford Medicine Study on Infection After Staff Stop Wearing MasksMay 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
